ASABYS PARTNERS
Asabys Partners is a venture capital firm that invests across the board in human healthcare. The company is active in the health-tech and biopharma industries and aims to invest in Spain and abroad in innovative and transformative technologies. Asabys Partners are motivated by the idea of pushing the boundaries of science and medicine. This is done through the sourcing and financing of the most disruptive technologies, and through the collaboration with the best internal and external talents of our industry.
ASABYS PARTNERS
Industry:
Biotechnology Life Science Medical Device Pharmaceutical
Founded:
2018-05-01
Status:
Active
Email Addresses:
[email protected]
Total Funding:
1.19 M USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default Google Font API Google Analytics LetsEncrypt Apple Mobile Web Clips Icon Google Tag Manager WordPress
Similar Organizations
Antengene Corporation
Antengene is a developer of biotechnology and bio-pharmaceuticals intended to provide medicine treatment for tumor.
Arcellx
Arcellx is a clinical-stage biotechnology company that provides patients with superior immune cell therapies.
Arctoris
Arctoris is a tech-enabled platform company in biotechnology, combining robotics & data science to accelerate drug discovery.
Axcella
Axcella is a biotechnology company providing therapeutics development solutions.
Braeburn
Braeburn is dedicated to delivering solutions for people living with the serious consequences of opioid use disorder.
Castle Creek Biosciences
Castle Creek Biosciences is focused on developing commercializing novel, personalized gene therapies for rare skin disorders.
Nuclera
Nuclera makes biology accessible through desktop enzymatic protein and gene synthesis.
PhaseBio Pharmaceuticals
PhaseBio is a clinical-stage biopharmaceutical company that develops drugs for cardiovascular diseases, endocrine, and metabolic disorders.
Syros Pharmaceuticals
Syros Pharmaceuticals is a life sciences company that focuses on treating diseases by mapping gene regulatory circuits.
Current Employees Featured
Founder
Investors List
Barcelona Ventures
Barcelona Ventures investment in Angel Round - Asabys Partners
Alantra
Alantra investment in Secondary Market - Asabys Partners
Investments List
| Date | Company | Article | Money raised |
|---|---|---|---|
| 2022-07-13 | AgomAb Therapeutics | Asabys Partners investment in Series B - AgomAb Therapeutics | 38.4 M EUR |
| 2022-06-28 | Amelia Virtual Care | Asabys Partners investment in Convertible Note - Amelia Virtual Care | 7 M EUR |
| 2022-06-13 | Cara Care | Asabys Partners investment in Series A - Cara Care | 7 M USD |
| 2022-05-05 | Sidekick Health | Asabys Partners investment in Series B - Sidekick Health | 55 M USD |
| 2022-02-15 | Splice Bio | Asabys Partners investment in Series A - Splice Bio | 50 M EUR |
| 2021-03-26 | INBRAIN Neuroelectronics | Asabys Partners investment in Series A - INBRAIN Neuroelectronics | 14.3 M EUR |
| 2021-02-10 | Medlumics | Asabys Partners investment in Venture Round - Medlumics | 18 M EUR |
| 2021-02-09 | Koa Health | Asabys Partners investment in Series A - Koa Health | 30 M EUR |
| 2020-10-28 | Sidekick Health | Asabys Partners investment in Series A - Sidekick Health | 20 M USD |
| 2020-09-15 | Splice Bio | Asabys Partners investment in Venture Round - Splice Bio | N/A |